FindTrial
Sign In

Envarsus XR

DRUG8 trials

Sponsors

University of California, Los Angeles, University of Colorado, Denver, Roberto Gedaly, University of Wisconsin, Madison, Methodist Healthcare

Conditions

Acute Rejection of Renal TransplantDelayed Graft FunctionDonor Specific AntibodiesEnd Stage Renal DiseaseGrafting, KidneyKidney Disease, End-StageKidney Pancreas TransplantationKidney Transplant Recipients

Phase 2

Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RecruitingNCT03321656
Roberto GedalyEnd Stage Renal Disease
Start: 2019-03-28End: 2027-03-31Target: 78Updated: 2026-03-24
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
RecruitingNCT03769298
University of Wisconsin, MadisonKidney Pancreas Transplantation
Start: 2019-02-27End: 2026-12-01Target: 20Updated: 2026-04-13
Envarsus XL Immunosuppression Following Liver Transplantation
CompletedNCT03828058
Methodist HealthcareRecipients of Liver Transplant
Start: 2019-04-01End: 2020-12-31Updated: 2021-01-12

Phase 4

Envarsus XR® in Adolescent Renal Transplant Recipients
Active, not recruitingNCT03266393
University of California, Los AngelesGrafting, Kidney, Kidney Transplantation, Renal Transplantation
Start: 2019-01-15End: 2023-03-31Target: 28Updated: 2023-02-09
CNS Study of Patients Switching From Tacrolimus to Envarsus
CompletedNCT03270462
University of Colorado, DenverRenal Transplant Patients
Start: 2017-12-01End: 2020-06-02Updated: 2022-06-02
Envarsus in Delayed Graft Function (E-DGF)
CompletedNCT03864926
University of Wisconsin, MadisonDelayed Graft Function
Start: 2019-03-18End: 2022-07-22Updated: 2023-07-20
Envarsus XR Compared to Immediate Release Tacrolimus
CompletedNCT03979365
Mayo ClinicKidney Transplant Recipients
Start: 2019-07-18End: 2022-03-29Updated: 2025-12-18
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
Active, not recruitingNCT04665310
The Methodist Hospital Research InstituteAcute Rejection of Renal Transplant, Donor Specific Antibodies, Kidney Disease, End-Stage
Start: 2018-09-01End: 2025-10-31Updated: 2025-03-14

Related Papers

Serum β2-Microglobulin Predicts Time to Recovery of Delayed Graft Function in Kidney Transplant Recipients.
2024-08-01
The FACT-GP5 as a global tolerability measure: responsiveness and robustness to missing assessments.
2024-07-243 citations
A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function.
2023-07-013 citations